Cochlear | COH - Ebit

Stock Price
173.86
Daily Change
1.50 0.87%
Monthly
-3.50%
Yearly
-32.18%
Q2 Forecast
168.62

Cochlear reported AUD261.1M in EBIT for its fiscal semester ending in December of 2025.





Ebit Change Date
Ansell USD 146.5M 29.2M Dec/2025
Avita Medical AUD -10.39M 1.72M Dec/2025
Cochlear AUD 261.1M 13.9M Dec/2025
CSL USD 2.64B 116M Dec/2025
Fisher Paykel Healthcare NZD 298.2M 2.8M Dec/2025
Healius AUD 23.7M 26M Dec/2024
Integral Diagnostics AUD 24.99M 5.08M Jun/2024
Mayne Pharma AUD -16.2M 13.2M Jun/2024
Mesoblast USD -27.75M 14.36M Dec/2025
Monash IVF AUD 18M 6.11M Dec/2025
Nanosonics AUD 9.12M 422K Dec/2025
Polynovo AUD 2.06M 1.18M Dec/2025
Ramsay Health Care AUD 541.1M 20.7M Dec/2025
Regis Healthcare AUD 24.67M 839K Dec/2025
ResMed USD 497.6M 35.25M Dec/2025
Sigma Healthcare AUD 809K 13.76M Dec/2024
Somnomed AUD -1.99M 83.11K Jun/2023
Sonic Healthcare AUD 423.94M 80.3M Dec/2024
Telix Pharmaceuticals AUD 8.04M 3.21M Dec/2025